Clinical Trial Detail

NCT ID NCT02096055
Title 4-Arm Phase II Study of SGI-110 in Elderly Acute Myeloid Leukemia (AML)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

acute myeloid leukemia

Therapies

Cladribine

Guadecitabine

Idarubicin

Age Groups: senior

No variant requirements are available.